Here's what I am seeing today: speculative buying based on the webinar announcement for a potential pump and dump going into Thursday.
Only thing that will change the SP med-long term is a collab with $ upfront or milestone payments involved.
So worst case scenario is that the HSV-2 Vax is a bomb. Right? In that case, we'd - I hope - see AHZ divest itself of the Immunotherapies division immediately making the company CF+ by a large margin in the next 6 months easy.
If not a bomb then we'd have to see a partnership/collab with the aforementioned up fronts/milestone to justify keep running it.
So we need decisive action on this now. If a CR is proffered to fund the operational costs of the Vax program I will be very very disappointed.
- Forums
- ASX - By Stock
- Ann: HSV-2 Phase IIa Results Investor Webinar
Here's what I am seeing today: speculative buying based on the...
-
- There are more pages in this discussion • 169 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 175 | $11.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.49 | 77 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 772 | 11.600 |
2 | 2000 | 11.500 |
1 | 80 | 11.250 |
1 | 500 | 11.050 |
2 | 600 | 11.000 |
Price($) | Vol. | No. |
---|---|---|
12.490 | 77 | 1 |
12.500 | 56 | 1 |
12.520 | 500 | 1 |
12.850 | 99 | 1 |
13.300 | 200 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |